Clover Health (CLOV) interim CFO discloses 1.24M shares, 912k RSUs on Form 3
Rhea-AI Filing Summary
Clover Health Investments Interim CFO Joseph Clay reported his initial beneficial ownership on a Form 3. He shows 1,238,684 shares of Class A common stock held directly, including 912,860 shares underlying the remaining unvested portion of restricted stock unit awards granted on February 16, 2024, October 15, 2024 and December 19, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
THORNTON JOSEPH CLAY
Role
Interim CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Class A Common Stock — 1,238,684 shares (Direct)
Footnotes (1)
- F1. The reported number of securities beneficially owned includes, in part, 912,860 shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying the remaining unvested portion, as of March 30, 2023, of time-based restricted stock unit awards originally granted to the Reporting Person on February 16, 2024, October 15, 2024 and December 19, 2025.
Key Figures
Beneficially owned shares: 1,238,684 shares
Unvested RSU underlying shares: 912,860 shares
RSU grant date: February 16, 2024
+2 more
5 metrics
Beneficially owned shares
1,238,684 shares
Class A Common Stock held directly following Form 3 entry
Unvested RSU underlying shares
912,860 shares
Remaining unvested portion of time-based RSU awards
RSU grant date
February 16, 2024
Original grant date for part of reported RSU awards
RSU grant date
October 15, 2024
Original grant date for part of reported RSU awards
RSU grant date
December 19, 2025
Original grant date for part of reported RSU awards
Key Terms
beneficially owned, Class A common stock, restricted stock unit
3 terms
beneficially owned financial
"The reported number of securities beneficially owned includes, in part, 912,860 shares"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Class A common stock financial
"912,860 shares of Class A common stock of Clover Health Investments, Corp."
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
restricted stock unit financial
"underlying the remaining unvested portion, as of March 30, 2023, of time-based restricted stock unit awards"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Joseph Clay’s Form 3 filing reveal about his Clover Health (CLOV) equity awards?
The Form 3 notes time-based restricted stock unit awards originally granted to Joseph Clay on February 16, 2024, October 15, 2024 and December 19, 2025. The remaining unvested portions of these awards correspond to 912,860 underlying Class A shares.
How is Joseph Clay’s ownership in Clover Health (CLOV) characterized in the Form 3 filing?
His ownership is reported as direct under the Class A common stock, with 1,238,684 shares beneficially owned. The footnote clarifies that this includes a substantial number of unvested restricted stock units that may settle into shares over time under their time-based vesting terms.